Evidence map›Paper›PMID 34258023›Full record

ArticleFuture science OA2021

Vancomycin heteroresistance in

Yamuna Devi Bathavatchalam, Dhanalakshmi Solaimalai, Anushree Amladi, Hariharan Triplicane Dwarakanathan, Shalini Anandan, Balaji Veeraraghavan

Abstract read
In one paragraph

Article in Future science OA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Epidemiology ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Emergence of multidrug-resistantEmerging microbes & infections · 2024
    Article
  7. Genetic Characterization of Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yamuna Devi BathavatchalamDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Dhanalakshmi SolaimalaiDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Anushree AmladiDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Hariharan Triplicane DwarakanathanDepartment of Orthopaedics, Christian Medical College, Vellore, India.
Shalini AnandanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.
Balaji VeeraraghavanDepartment of Clinical Microbiology, Christian Medical College, Vellore, India.ORCID https://orcid.org/0000-0002-8662-4257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the presence of vancomycin heteroresistance in MATERIALS &

methodsA total of 48 rifampicin-resistant

resultsFifteen isolates were identified as heteroresistant vancomycin-intermediate

conclusionThese findings illustrate the potential of

Indexed as

antibioticsdrug developmentdrug resistanceepidemiologyinfectious disease

Identifiers

PMID34258023
PMCPMC8256318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.